According to the Zhitong Finance App, Weigao Co., Ltd. (01066) announced interim results for the six months ended June 30, 2026. The group obtained revenue of 6.849 billion yuan, an increase of 3.08%; profit attributable to company owners was 774 million yuan, a year-on-year decrease of 23.23%; profit per share was 0.17 yuan, and an interim dividend of 0.0854 yuan per share was planned.

During this period, the turnover of medical device products was approximately RMB 3.364 billion, an increase of 5.4% over the same period. Despite an increase in turnover, operating profit declined by nearly 10% year-on-year due to price cuts for several core products due to collection policies starting in the third quarter of 2025. Despite this, by adjusting the product structure and greatly optimizing marketing expenses, the company achieved a significant month-on-month increase in operating profit, and the operating profit margin stabilized at more than 10%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.